Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 6/2003

01-08-2003 | Originales

Experiencia en la utilización del fentanilo transdérmico en un servicio de Oncología radioterápica

Authors: Jorge Contreras Martínez, Ismael Herruzo Cabrera, Asunción Villanueva Álvarez, Amadeo Wals Zurita, Raquel Correa Generoso, Alberto Domínguez Mayoral, José María Azcoaga Blasco, Raquel Delgado Rico, Inmaculada Fortes de la Torre e Isabel García Ríos

Published in: Clinical and Translational Oncology | Issue 6/2003

Login to get access
Metadata
Title
Experiencia en la utilización del fentanilo transdérmico en un servicio de Oncología radioterápica
Authors
Jorge Contreras Martínez
Ismael Herruzo Cabrera
Asunción Villanueva Álvarez
Amadeo Wals Zurita
Raquel Correa Generoso
Alberto Domínguez Mayoral
José María Azcoaga Blasco
Raquel Delgado Rico
Inmaculada Fortes de la Torre e Isabel García Ríos
Publication date
01-08-2003
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 6/2003
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02709989

Other articles of this Issue 6/2003

Clinical and Translational Oncology 6/2003 Go to the issue

Originales

CHOP con intensificación de dosis en linfomas no Hodgkin agresivos

Revisiones

p38 mitogen-activated protein kinases: their role in carcinogenesis

Notas Clínicas

Multiple neuroblastoma or multiple diseases?

Originales

Intraoperative ultrasound for ethanol tumor ablation and liver resection for malignant tumors

Notas Clínicas

Massive intra-peritoneal non-functioning malignant paraganglioma

Announcement

Información
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits